Discover
CSTL
Castle Biosciences, Inc.
34.42
2 x 22.02
2 x 40.14
bid
ask
+
0.71
2.11%
2 @ 04:01 PM
34.42 +0.00 (0.00%)
| Ytd | -11.52% | |
| 1y | 45.48% |
33.46
day range
34.52
18.15
52 week range
43.04
| Open | 33.55 | Prev Close | 33.71 | Low | 33.46 | High | 34.52 | Mkt Cap | 1.05B |
| Vol | 249.09K | Avg Vol | 402.90K | EPS | -0.65 | P/E | N/A | Forward P/E | -36.66 |
| Beta | 0.94 | Short Ratio | 5.73 | Inst. Own | 91.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-02 | 50-d Avg | 33.11 | 200-d Avg | 28.98 | 1yr Est | 45.22 |
| Income Statement | |||
| Total Revenue | 103.55M | ||
| Revenues (USD) | 103.55M | ||
| Cost of Revenue | 23.70M | ||
| Gross Profit | 79.85M | ||
| Operating Expenses | 82.92M | ||
| Research and Development Expense | 14.54M | ||
| Selling, General and Administrative Expense | 66.12M | ||
| Operating Income | -3.07M | ||
| Interest Expense | 193.00K | ||
| Income Tax Expense | 370.00K | ||
| Net Income | -2.06M | ||
| Net Income Common Stock | -2.06M | ||
| Net Income Common Stock (USD) | -2.06M | ||
| Consolidated Income | -2.06M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -1.50M | ||
| Earning Before Interest & Taxes (USD) | -1.50M | ||
| Weighted Average Shares | 30.40M | ||
| Weighted Average Shares Diluted | 30.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 62.12M | ||
| Cash and Equivalents (USD) | 62.12M | ||
| Investments | 204.69M | ||
| Investments Current | 204.69M | ||
| Trade and Non-Trade Receivables | 50.00M | ||
| Current Assets | 341.10M | ||
| Property, Plant & Equipment Net | 118.88M | ||
| Total Assets | 561.18M | ||
| Debt Current | 4.33M | ||
| Total Debt | 36.65M | ||
| Current Liabilities | 56.51M | ||
| Debt Non-Current | 32.32M | ||
| Total Liabilities | 91.15M | ||
| Accumulated Retained Earnings (Deficit) | -240.87M | ||
| Accumulated Other Comprehensive Income | -256.00K | ||
| Shareholders Equity | 470.03M | ||
| Shareholders Equity (USD) | 470.03M | ||
| Assets Non-Current | 220.08M | ||
| Total Debt (USD) | 36.65M | ||
| Goodwill and Intangible Assets | 95.10M | ||
| Inventory | 10.58M | ||
| Liabilities Non-Current | 34.64M | ||
| Trade and Non-Trade Payables | 9.67M | ||
| Tax Liabilities | 2.32M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.07M | ||
| Net Cash Flow from Financing | -886.00K | ||
| Capital Expenditure | -8.64M | ||
| Issuance (Purchase) of Equity Shares | 931.00K | ||
| Issuance (Repayment) of Debt Securities | -24.00K | ||
| Net Cash Flow from Investing | -15.96M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -7.32M | ||
| Net Cash Flow from Operations | 15.20M | ||
| Share Based Compensation | 11.59M | ||